Overview of resistance in the 1990s

Chest

Volumn 115, Issue 3 SUPPL., 1999, Pages 3S-8S

  File Jr , Thomas M ^a,b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

Author keywords

Antimicrobials; Cephalosporins; Methicillin resistant Staphylococcus aureus; Nosocomial infections; Resistance

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; MACROLIDE; METICILLIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

AGRICULTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0345222514     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.suppl_1.3S     Document Type: Article

References (32)

1. US Congress, Office of Technology and Assessment. Impacts of antibiotic-resistant bacteria [abstract]. Washington, DC: Office of Technology and Assessment, 1995; OTA-H-629
2. Archibald L, Phillips L, Monnet D, et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24:211-215
3. Barg N. New resistance mechanisms of common bacterial pathogens. Contemp Intern Med 1995; 7:61-69
4. Shlaes DM, Rice LB. Emerging mechanisms of B-lactam resistance: an update. Infect Dis in Clin Prac 1995; 15:35-85
5. Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med 1996; 335:1445-1453
6. Thornsberry C. Trends in antimicrobial resistance among today's bacterial pathogens. Pharmacotherapy 1995; 15(1 pt 2): 3S-8S
7. Neu HC. The crisis in antibiotic resistance. Science 1992; 257:1064-1073
8. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria: a report on the Rockefeller University Workshop. N Engl J Med 1994; 330:1247-1251
9. Feinman SE. Antibiotics in animal feed - drug resistance revisited. ASM News 1998; 64:24-30
10. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24(suppl 1):S19-S45
11. Cohen ML. Antimicrobial resistance: prognosis of public health. Trends Microbiol 1994; 10:422-425
12. Doern GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997; 41:292-297
13. Pichichero ME. Resistant respiratory pathogens and extended-spectrum antibiotics. Am Fam Physician 1995; 52:1739-1746
14. Doern GV, Brueggemann A, Holley HP Jr, et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40:1208-1213
15. Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn Microbiol Infect Dis 1997; 29:249-257
16. Feikin D, Cetron FD, Schuchat A. Multi-state population based assessment of mortality from drug resistant Streptococcus pneumoniae [abstract]. 35th Annual Meeting of the Infectious Diseases Society of America: September 13-16, 1997; San Francisco, CA; abstract 48
17. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-598
18. Moreno F, Crisp C, Jorgensen JH, et al. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995; 21:1308-1312
19. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997; 11:757-765
20. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91(suppl 3B):72S-75S
21. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 1996; 100(suppl 6A):3S-12S
22. Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996; 17:236-248
23. Jones RN, Kehrberg EN, Erwin ME, et al. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States: I. Study on the threat of emerging resistances: real or perceived? Diagn Microbiol Infect Dis 1994; 19:203-215
24. Vincent J-L, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274:639-644
25. Brown RB, Colodny SM, Drapkin MS. One day prevalence study of 118 intensive care units (ICUs). Paper presented at: Fifth annual meeting of Healthcare Epidemiology of America; April 2-4, 1995; San Diego, CA
26. Ena J, Dick RW, Jones RN, et al. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993; 269:598-602
27. Eliopoulos GM. Vancomycin-resistant enterococci: mechanism and clinical relevance. Infect Dis Clin North Am 1997; 11:851-865
28. Meyer KS. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-358
29. Rice LB, Eckstein EC, DeVente J, et al. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23:118-124
30. Levy SB. Confronting multidrug resistance: a role for each of us. JAMA 1993; 269:1840-1842
31. Murray BE. Can antibiotic resistance be controlled? N Engl J Med 1994; 330:1229-1230
32. Jernigan DB, Cetron MS, Breiman RF. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR Morb Mortal Wkly Rep 1996; 45:1-20